QuidelOrtho Corporation f/k/a Quidel Corporation Class Action Lawsuit - QDEL

The filed complaint alleges that QuidelOrtho Corporation f/k/a Quidel Corporation made materially false and/or misleading statements and/or failed to disclose that: (a) that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers; (b) that excess inventories of COVID-19 tests existed throughout the supply chain; (c) that, as a result of (a)-(b) above, QuidelOrtho’s distributors and pharmacy chain customers were poised to significantly reduce their COVID-19 test orders; (d) that undisclosed problems created a heightened risk that the new test called the savanna respiratory viral panel-4 test would experience a delayed commercial launch in the united states; (e) that, as a result of (a)-(d) above, defendants lacked a reasonable basis for their positive statements about QuidelOrtho’s business, financials, and growth trajectory.

In order to be eligible to join the QDEL class action lawsuit, you must have incurred a loss on shares of QuidelOrtho purchased during the class period listed above.

If you suffered a loss in QuidelOrtho during the relevant time frame or pursuant to the relevant offering(s), you have until June 11, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.